EVUNZEKIBART
UNII AKZ8CT8FMF

Substance Identification & Data

This profile provides standardized clinical and technical data for Evunzekibart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) AKZ8CT8FMF.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2639688-77-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
AKZ8CT8FMF
CAS Registry Number
2639688-77-8
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
EVUNZEKIBART
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C173548
National Cancer Institute reference terminology for clinical and research data.
INN ID
12262
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Evunzekibart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

EVUNZEKIBART

Common Names & Synonyms

ATOR 1017 [WHO-DD]
EVUNZEKIBART [INN]
IMMUNOGLOBULIN G4 (226-PROLINE), ANTI-(HUMAN TUMOR NECROSIS FACTOR RECEPTOR TNFRSF9) (HUMAN MONOCLONAL ATOR-1017 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL ATOR-1017 .KAPPA.-CHAIN, DIMER

Technical Codes

ATOR-1017

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus